Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Dibigatran market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Dibigatran market segmented into
Pradaxa
Pradax
Prazaxa
Based on the end-use, the global Dibigatran market classified into
stroke
deep vein thrombosis
pulmonary embolism
systemic embolism
Based on geography, the global Dibigatran market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pfizer, Inc. (US)
Bayer Healthcare AG (Germany)
GlaxoSmithKline Plc. (UK)
Boehringer Ingelheim (Germany)
Sanofi S.A. (France)
Abbott India Limited (India)
Aspen Holdings (South Africa)
Bristol-Myers Squibb Company (US)
Eisai Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Teva Pharmaceutical Industries Ltd. (Israel)
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DIBIGATRAN INDUSTRY
2.1 Summary about Dibigatran Industry
2.2 Dibigatran Market Trends
2.2.1 Dibigatran Production & Consumption Trends
2.2.2 Dibigatran Demand Structure Trends
2.3 Dibigatran Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Pradaxa
4.2.2 Pradax
4.2.3 Prazaxa
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 stroke
4.3.2 deep vein thrombosis
4.3.3 pulmonary embolism
4.3.4 systemic embolism
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Pradaxa
5.2.2 Pradax
5.2.3 Prazaxa
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 stroke
5.3.2 deep vein thrombosis
5.3.3 pulmonary embolism
5.3.4 systemic embolism
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Pradaxa
6.2.2 Pradax
6.2.3 Prazaxa
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 stroke
6.3.2 deep vein thrombosis
6.3.3 pulmonary embolism
6.3.4 systemic embolism
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Pradaxa
7.2.2 Pradax
7.2.3 Prazaxa
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 stroke
7.3.2 deep vein thrombosis
7.3.3 pulmonary embolism
7.3.4 systemic embolism
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Pradaxa
8.2.2 Pradax
8.2.3 Prazaxa
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 stroke
8.3.2 deep vein thrombosis
8.3.3 pulmonary embolism
8.3.4 systemic embolism
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Pradaxa
9.2.2 Pradax
9.2.3 Prazaxa
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 stroke
9.3.2 deep vein thrombosis
9.3.3 pulmonary embolism
9.3.4 systemic embolism
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pfizer, Inc. (US)
10.1.2 Bayer Healthcare AG (Germany)
10.1.3 GlaxoSmithKline Plc. (UK)
10.1.4 Boehringer Ingelheim (Germany)
10.1.5 Sanofi S.A. (France)
10.1.6 Abbott India Limited (India)
10.1.7 Aspen Holdings (South Africa)
10.1.8 Bristol-Myers Squibb Company (US)
10.1.9 Eisai Inc. (US)
10.1.10 Mitsubishi Tanabe Pharma Corporation (Japan)
10.1.11 Teva Pharmaceutical Industries Ltd. (Israel)
10.2 Dibigatran Sales Date of Major Players (2017-2020e)
10.2.1 Pfizer, Inc. (US)
10.2.2 Bayer Healthcare AG (Germany)
10.2.3 GlaxoSmithKline Plc. (UK)
10.2.4 Boehringer Ingelheim (Germany)
10.2.5 Sanofi S.A. (France)
10.2.6 Abbott India Limited (India)
10.2.7 Aspen Holdings (South Africa)
10.2.8 Bristol-Myers Squibb Company (US)
10.2.9 Eisai Inc. (US)
10.2.10 Mitsubishi Tanabe Pharma Corporation (Japan)
10.2.11 Teva Pharmaceutical Industries Ltd. (Israel)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Dibigatran Product Type Overview
Table Dibigatran Product Type Market Share List
Table Dibigatran Product Type of Major Players
Table Brief Introduction of Pfizer, Inc. (US)
Table Brief Introduction of Bayer Healthcare AG (Germany)
Table Brief Introduction of GlaxoSmithKline Plc. (UK)
Table Brief Introduction of Boehringer Ingelheim (Germany)
Table Brief Introduction of Sanofi S.A. (France)
Table Brief Introduction of Abbott India Limited (India)
Table Brief Introduction of Aspen Holdings (South Africa)
Table Brief Introduction of Bristol-Myers Squibb Company (US)
Table Brief Introduction of Eisai Inc. (US)
Table Brief Introduction of Mitsubishi Tanabe Pharma Corporation (Japan)
Table Brief Introduction of Teva Pharmaceutical Industries Ltd. (Israel)
Table Products & Services of Pfizer, Inc. (US)
Table Products & Services of Bayer Healthcare AG (Germany)
Table Products & Services of GlaxoSmithKline Plc. (UK)
Table Products & Services of Boehringer Ingelheim (Germany)
Table Products & Services of Sanofi S.A. (France)
Table Products & Services of Abbott India Limited (India)
Table Products & Services of Aspen Holdings (South Africa)
Table Products & Services of Bristol-Myers Squibb Company (US)
Table Products & Services of Eisai Inc. (US)
Table Products & Services of Mitsubishi Tanabe Pharma Corporation (Japan)
Table Products & Services of Teva Pharmaceutical Industries Ltd. (Israel)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Dibigatran Market Forecast (Million USD) by Region 2021f-2026f
Table Global Dibigatran Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Dibigatran Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Dibigatran Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Dibigatran Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dibigatran Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dibigatran Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dibigatran Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dibigatran Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Dibigatran Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Dibigatran Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradax Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prazaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure stroke Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure deep vein thrombosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure pulmonary embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure systemic embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradax Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prazaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure stroke Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure deep vein thrombosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure pulmonary embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure systemic embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradax Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prazaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure stroke Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure deep vein thrombosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure pulmonary embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure systemic embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradax Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prazaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure stroke Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure deep vein thrombosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure pulmonary embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure systemic embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradax Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prazaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure stroke Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure deep vein thrombosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure pulmonary embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure systemic embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pradax Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Prazaxa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure stroke Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure deep vein thrombosis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure pulmonary embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure systemic embolism Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dibigatran Sales Revenue (Million USD) of Pfizer, Inc. (US) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Bayer Healthcare AG (Germany) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of GlaxoSmithKline Plc. (UK) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Boehringer Ingelheim (Germany) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Sanofi S.A. (France) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Abbott India Limited (India) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Aspen Holdings (South Africa) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Bristol-Myers Squibb Company (US) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Eisai Inc. (US) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Mitsubishi Tanabe Pharma Corporation (Japan) 2017-2020e
Figure Dibigatran Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd. (Israel) 2017-2020e